Revisiting the cholinergic hypothesis in the development of Alzheimer's disease
β Scribed by Laura A. Craig; Nancy S. Hong; Robert J. McDonald
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 350 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0149-7634
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A cerebral cortical cholinergic reduction in dominantly inherited olivopontocerebellar atrophy (OPCA) was recently described. Although the magnitude of the cholinergic reduction was similar to that observed in Alzheimer's disease (AD), none of the OPCA patients was reported to have been demented. We
## Abstract Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive impairment and behavioral changes. Cholinesterase inhibitors are currently the drugs of choice for the treatment of AD. However, alternatives to cholinesterase inhibitors such as muscarinic and nicotinic
## Abstract The article reviews evidence for the efficacy of the aminoacridines (tacrine, velnacrine) in patients with probable Alzheimer's disease (AD). The discussion revolves around the question of the clinical relevance of the treatment effects observed. Other questions discussed deal with the